Product Pedigree

Ron Bone, MBA

Sr. Vice President, Distribution Support
McKesson Pharmaceutical
 Session Agenda

 Marketplace Trends
• Trends of a growing problem
• Growth of state legislation
 Pedigree Overview
• Industry collaboration
• RFID
 Pharmacy Considerations

2 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

Marketplace Trends
 The FDA has been Opening Cases Since 1997

4 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 There has been Recent Negative Press Coverage

Drugstore Cowboys
The Dangerous Traffic in Fake
Prescription Medicines

Vanity Fair May 05

5 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Counterfeit Labeling Of Epogen

6 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 FDA Combating Counterfeit Drugs
February 2004
• Called for the use of RFID

December 2004
• Called for Pedigree Database

May 2005
• Called for Electronic Track
and Trace
May 2006
• PDMA Final Rule effective
12/2/06. Reaffirms RFID
Dropped the central Database

7 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 DRAFT
PDMA 1999 Final Rule
(if implemented as currently written)

No Pedigree
1. ADR to Pharmacy Pharmacy
Mfr. ADR

No Pedigree No Pedigree
2. ADR - ADR
Mfr. ADR ADR Pharmacy

No Pedigree
3. ADR Required
Pedigree
Pharmacy
To Mfr. ADR (Defacto Non-ADR Back to Mfr. or Another
Non-ADR Pedigree Dates, Lot #, etc. Distributor
Implied)

No No
Pedigree Pedigree
4. ADR Pedigree
Cleansing Mfr. ADR (Defacto
Non-ADR Back to
ADR Pharmacy
Pedigree Mfr. Dates,
Implied) Lot #, etc.
Explanation
• By “defacto” pedigree, we mean that even though the rule doesn’t require a pedigree for an ADR to sell to another ADR, the first ADR must supply the pedigree
information for the second one so that the second one may meet the rule’s requirements.
• Pedigrees must contain the following information for all transactions going back to the manufacturer: Drug names, Dosage, Container size, Number of containers,
8 Lot #,Pharmacy
Business name and Purchasing Outlook
address of all parties Networking
to each prior Conference
transaction (including manufacturer). August 9, 2006
 28 States - Pending or Passed Pedigree Legislation

Disclaimer: This map summarizes the states who have passed or introduced pedigree legislation. This map is not intended to be legal or
9
regulatoryPharmacy Purchasing
advice on pedigree legislation.Outlook Networking Conference
August 9, 2006
 Pedigree Overview

Objective:

To ensure a safe and secure supply

chain.
Electronic pedigree provides efficient
and paperless technology to achieve
this.

10 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Pedigree Overview

TERM DEFINITION

A record of a drug's chain of custody, from

Pharmaceutical
the point of manufacture to the point of
Pedigree dispensing.

Electronic pedigree track and trace (chain of

E-pedigree custody) information on product information.

Radio Frequency Identification using

RFID electronic product code (EPC).
Technology

11 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Pedigree Overview

Strategic Benefits Long-term

Operational Benefits
• Faster, more accurate
shipping and receiving
• Counterfeit prevention
• Potential labor savings and
• Recall precision inventory costs
• Brand value • Expedited Returns
protection processing

• Compliance with
Prescription Drug Marketing
Act (PDMA) and State
requirements

12 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

Radio Frequency Identification
(RFID)
 RFID Gen2 Chip – Available Fall 2005

14 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Gen2 Chip has 48,000 Transistors

15 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 RFID Tag and Terminology

RFID Tag

IC – “Chip”

16 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 RFID Tag and Terminology

TERM DEFINITION

A microchip attached to an antenna. The tag

Tag draws energy from an electromagnetic field
created by the reader.

Communicates with RFID tags and passes

Reader information in digital form to a computer system.

Electronic Product Code is the coding standard

EPC used to identify an item. Similar to UPC code with
the addition of serialization.

17 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 RFID vs. Bar code

Barcode Data Matrix 2D

RFID

18 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

Pilot Projects
2002-2006
 RFID Evaluation - Jumpstart Project
Program Management

Manufacturers Wholesalers Retailers

Regulatory &
Trade

20 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Business Scenarios Approach

Validate Benefits
Category Issues
• Regulatory Compliance
Safe & Secure • Product Security
Supply Chain • Consumer Safety
• Theft / Shrink Management

• Expiration Dating Management

• Lot & Batch Tracking
Reverse Logistics
• Returns Management
• Recall Expediting

• Shipping Accuracy
Operational
• Receiving Accuracy
Efficiencies • Operational Productivity

21 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 On Track

Mission Statement:
 Drive towards a safe and secure supply chain
while increasing cost efficiency and the
quality of health care through pharmaceutical
serialization strategies.

22 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 On Track Participants

Manufacturer Retailer Wholesale

Partners Partners Distributors
 GlaxoSmithKline  Rite Aid  Cardinal Health
 Novartis  Target  McKesson
 Pfizer  Walgreens
 Wal-Mart
 Purdue
 Roche

23 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 On Track is an Opportunity to…

• Bring together trading partners and create a living

laboratory across the supply chain to advance product
safety, item serialization, and the quality of healthcare

• Leverage the learnings and momentum of industry

leading companies to reduce costs and development
time

• Gain real-world experience with product serialization in a

technology-agnostic environment

24 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 On Track is an Opportunity to…

• Leverage learnings into practical commercial

serialization installations

• Provide fact-based information to the membership, the

industry, the technology community and policy makers

25 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Challenges for Potential Solutions

 Competing electronic technologies

• Various primary electronic tags i.e. 2D bar codes (line-of-sight)
• Non-Standard tags
• Bar code vs. RFID (backwards track)
 Manufacturers Serializing all Rx products
 States requiring different data elements
 Data Sharing (Peer to Peer vs. Shared Network)
 Technology and standards continue to evolve
 Adoption time across industry

26 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 RFID Activity and Future Considerations

 EPCglobal is the standards setting body for RFID/EPC

 Industry segments work with EPCglobal Business Action

Groups
• Healthcare & Life Sciences is the business action group for
pharmaceuticals and medical devices

 Generation 2 Tags
• Became available in fall of 2005
• Superior reads
• Superior penetration into the case/pallet
• Encryption
• Tag
27 Pharmacy kill feature
Purchasing Outlook Networking Conference August 9, 2006
 Considerations for Pharmacy

What is happening in your state on

pedigree?

• Is there a way for you to influence the

legislation or regulations to achieve the goal of
improved patient safety?

28 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Considerations for Pharmacy

How will you store and provide

pedigree information, upon
request?

29 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Considerations for Pharmacy

Does the PDMA final rule impact

your pharmacy operation?

30 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 Considerations for Pharmacy

Are you aware of the most commonly

counterfeited items?

• National Association of Boards of Pharmacy

(NABP®) lists of 34 specified list of susceptible
products.

31 Pharmacy Purchasing Outlook Networking Conference August 9, 2006

 National Specified List of Susceptible Products
 Bextra (Valdecoxib)  Risperdal (risperidone)
 Celebrex (Celecoxib)  Rocephin (ceftriaxone)
 Combivir (lamivudine/zidovudine)  Serostim (somatropin, mannalian
 Crixivan (indinavir) derived)
 Diflucan (fluconazole)  Sustiva (efavirenz)
 Epivir (lamivudine)  Trizivir
 (abacavir/lamivudine/zidovudine)
Epogen (epoetin alfa)
 Gamimune (globulin, immune)
 Venoglobulin (globulin, immune)
 Gammagard (globulin, immune)
 Viagra (sildenafil)
 Immune globuin
 Videx (didanosine)
 Lamisil (terbinafine)
 Viracept (nelfinavir)
 Lipitor (atorvastatin)
 Viramune (nevirapine)
 Lupron (leuprolide)
 Zerit (stavudine)
 Neupogen (filgrastim)
 Ziagen (abacavir)
 Nutropin AQ (somatropin, E-coli
 Zocor (simvastatin)
derived)  Zofran (ondansetron)
 Panglobulin (globulin, immune)  Zoladex (goserelin)
 Procrit (epoetin alfa)  Zyprexa (olanzapine)
 Retrovir (zidovudine)

32 Pharmacy Purchasing
National Association of Boards Outlook
of Pharmacy,Networking
2004 Conference August 9, 2006
Questions?